Clinical Trial Update: Rare Tumors and Cancer Predisposition in Individuals and Families

View source ↗

Summary

National Cancer Institute is recruiting participants for a study on rare tumors and cancer predisposition in individuals and families.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Genetic Predisposition to Cancer
• Hereditary Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer, Hereditary Neoplasms | Status: RECRUITING